Flu deaths trigger rise of biotech stocks

Recent headlines about a cluster of avian flu deaths in Indonesia could be felt among biotech companies working on the virus. A host of stocks, from Novavax to BioCryst to Generex and more, saw their stocks go up as investors reacted to the headlines by buying up shares. Analysts say that every time a new headline hits newspapers and the Internet, we're likely to experience gyrations on the stock market.

- here's the report from the Philadelphia Inquirer

PLUS: The World Health Organization is sending a team of experts to study the cluster. Article

ALSO: The feds say a host of avian flu drugs on the market are fake. Report

Suggested Articles

In this week's EuroBiotech Report, GSK, Immatics strike cell therapy deal, Vifor buys priority review voucher and PharmaMar gets PDUFA date.

In our EuroBiotech roundup this week, U.K. creates life science zones, Genmab to ramp up R&D spending and Pfizer backs cancer biotech. 

Spruce Biosciences raised $88 million from the likes of Abingworth and Omega Funds to take the drug to the next level: a late-stage study in adults.